The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

doi:10.1083/jcb.200403069

Published online 12 July 2004. doi:10.1083/jcb.200403069
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 166, Number 2, 213-223

This Article

	Full Text
	PDF (Full Text)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Harrington, L. S.
	Articles by Lamb, R. F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Harrington, L. S.
	Articles by Lamb, R. F.


Social Bookmarking

	What's this?

Article

The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins

Laura S. Harrington¹, Greg M. Findlay¹, Alex Gray², Tatiana Tolkacheva¹, Simon Wigfield¹, Heike Rebholz³, Jill Barnett², Nick R. Leslie², Susan Cheng⁴, Peter R. Shepherd⁴, Ivan Gout³, C. Peter Downes², and Richard F. Lamb¹

¹ Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, London SW3 6JB, England, UK
² School of Life Sciences Research Biocentre, University of Dundee, Dundee DD1 4HN, Scotland, UK
³ Ludwig Institute for Cancer Research, Royal Free and University College Medical School Branch, London W1W 7BS, England, UK
⁴ Department of Biochemistry, University College London, London WC1E 6BT, England, UK

Address correspondence to Richard F. Lamb, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Rd., London SW3 6JB, England, UK. Tel.: (44) 207-970-6096. Fax: (44) 207-352-5630. email: Richard.Lamb{at}icr.ac.uk

Insulin-like growth factors elicit many responses through activationof phosphoinositide 3-OH kinase (PI3K). The tuberous sclerosiscomplex (TSC1-2) suppresses cell growth by negatively regulatinga protein kinase, p70S6K (S6K1), which generally requires PI3Ksignals for its activation. Here, we show that TSC1-2 is requiredfor insulin signaling to PI3K. TSC1-2 maintains insulin signalingto PI3K by restraining the activity of S6K, which when activatedinactivates insulin receptor substrate (IRS) function, via repressionof IRS-1 gene expression and via direct phosphorylation of IRS-1.Our results argue that the low malignant potential of tumorsarising from TSC1-2 dysfunction may be explained by the failureof TSC mutant cells to activate PI3K and its downstream effectors.

Key Words: TSC1-2; PI3K; IRS proteins; S6K; insulin

L.S. Harrington and G.M. Findlay contributed equally to thispaper.

Abbreviations used in this paper: IRS, insulin receptor substrate;MEF, mouse embryo fibroblast; mTOR, mammalian target of rapamycin;PI3K, phosphoinositide 3-OH kinase; PIP3, phosphatidylinositol3,4,5-trisphosphate; PTB, phosphotyrosine-binding domain; siRNA,small interfering RNA; TSC, tuberous sclerosis complex.

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Huang, J., Dibble, C. C., Matsuzaki, M., Manning, B. D. (2008). The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2. Mol. Cell. Biol. 28: 4104-4115 [Abstract] [Full Text]
Jiang, X., Kenerson, H., Aicher, L., Miyaoka, R., Eary, J., Bissler, J., Yeung, R. S. (2008). The Tuberous Sclerosis Complex Regulates Trafficking of Glucose Transporters and Glucose Uptake. Am. J. Pathol. 172: 1748-1756 [Abstract] [Full Text]
McNeill, H., Craig, G. M., Bateman, J. M. (2008). Regulation of Neurogenesis and Epidermal Growth Factor Receptor Signaling by the Insulin Receptor/Target of Rapamycin Pathway in Drosophila. Genetics 179: 843-853 [Abstract] [Full Text]
Meikle, L., Pollizzi, K., Egnor, A., Kramvis, I., Lane, H., Sahin, M., Kwiatkowski, D. J. (2008). Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function. J. Neurosci. 28: 5422-5432 [Abstract] [Full Text]
Shigeyama, Y., Kobayashi, T., Kido, Y., Hashimoto, N., Asahara, S.-i., Matsuda, T., Takeda, A., Inoue, T., Shibutani, Y., Koyanagi, M., Uchida, T., Inoue, M., Hino, O., Kasuga, M., Noda, T. (2008). Biphasic Response of Pancreatic {beta}-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice. Mol. Cell. Biol. 28: 2971-2979 [Abstract] [Full Text]
Bae, E. J., Yang, Y. M., Kim, S. G. (2008). Abrogation of Hyperosmotic Impairment of Insulin Signaling by a Novel Class of 1,2-Dithiole-3-thiones through the Inhibition of S6K1 Activation. Mol. Pharmacol. 73: 1502-1512 [Abstract] [Full Text]
Cederroth, C. R., Vinciguerra, M., Gjinovci, A., Kuhne, F., Klein, M., Cederroth, M., Caille, D., Suter, M., Neumann, D., James, R. W., Doerge, D. R., Wallimann, T., Meda, P., Foti, M., Rohner-Jeanrenaud, F., Vassalli, J.-D., Nef, S. (2008). Dietary Phytoestrogens Activate AMP-Activated Protein Kinase With Improvement in Lipid and Glucose Metabolism. Diabetes 57: 1176-1185 [Abstract] [Full Text]
Zeng, X., Kinsella, T. J. (2008). Mammalian Target of Rapamycin and S6 Kinase 1 Positively Regulate 6-thioguanine-Induced Autophagy. Cancer Res. 68: 2384-2390 [Abstract] [Full Text]
Fraenkel, M., Ketzinel-Gilad, M., Ariav, Y., Pappo, O., Karaca, M., Castel, J., Berthault, M.-F., Magnan, C., Cerasi, E., Kaiser, N., Leibowitz, G. (2008). mTOR Inhibition by Rapamycin Prevents {beta}-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes. Diabetes 57: 945-957 [Abstract] [Full Text]
Koketsu, Y., Sakoda, H., Fujishiro, M., Kushiyama, A., Fukushima, Y., Ono, H., Anai, M., Kikuchi, T., Fukuda, T., Kamata, H., Horike, N., Uchijima, Y., Kurihara, H., Asano, T. (2008). Hepatic overexpression of a dominant negative form of raptor enhances Akt phosphorylation and restores insulin sensitivity in K/KAy mice. Am. J. Physiol. Endocrinol. Metab. 294: E719-E725 [Abstract] [Full Text]
Kong, D., Banerjee, S., Huang, W., Li, Y., Wang, Z., Kim, H.-R. C., Sarkar, F. H. (2008). Mammalian Target of Rapamycin Repression by 3,3'-Diindolylmethane Inhibits Invasion and Angiogenesis in Platelet-Derived Growth Factor-D-Overexpressing PC3 Cells. Cancer Res. 68: 1927-1934 [Abstract] [Full Text]
Kim, J.-H., Kim, J. E., Liu, H.-Y., Cao, W., Chen, J. (2008). Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway. J. Biol. Chem. 283: 708-715 [Abstract] [Full Text]
Meske, V., Albert, F., Ohm, T. G. (2008). Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3 -dependent Phosphorylation of Tau. J. Biol. Chem. 283: 100-109 [Abstract] [Full Text]
Tamburini, J., Chapuis, N., Bardet, V., Park, S., Sujobert, P., Willems, L., Ifrah, N., Dreyfus, F., Mayeux, P., Lacombe, C., Bouscary, D. (2008). Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Blood 111: 379-382 [Abstract] [Full Text]
Martin, K. A., Merenick, B. L., Ding, M., Fetalvero, K. M., Rzucidlo, E. M., Kozul, C. D., Brown, D. J., Chiu, H. Y., Shyu, M., Drapeau, B. L., Wagner, R. J., Powell, R. J. (2007). Rapamycin Promotes Vascular Smooth Muscle Cell Differentiation through Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase/Akt2 Feedback Signaling. J. Biol. Chem. 282: 36112-36120 [Abstract] [Full Text]
Kakazu, E., Kanno, N., Ueno, Y., Shimosegawa, T. (2007). Extracellular Branched-Chain Amino Acids, Especially Valine, Regulate Maturation and Function of Monocyte-Derived Dendritic Cells. J. Immunol. 179: 7137-7146 [Abstract] [Full Text]
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., Chin, L., DePinho, R. A., Cavenee, W. K. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21: 2683-2710 [Abstract] [Full Text]
Ruffolo, S. C., Forsell, P. K. A., Yuan, X., Desmarais, S., Himms-Hagen, J., Cromlish, W., Wong, K. K., Kennedy, B. P. (2007). Basal Activation of p70S6K Results in Adipose-specific Insulin Resistance in Protein-tyrosine Phosphatase 1B / Mice. J. Biol. Chem. 282: 30423-30433 [Abstract] [Full Text]
Lun, X. Q., Zhou, H., Alain, T., Sun, B., Wang, L., Barrett, J. W., Stanford, M. M., McFadden, G., Bell, J., Senger, D. L., Forsyth, P. A. (2007). Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin. Cancer Res. 67: 8818-8827 [Abstract] [Full Text]
Tremblay, F., Brule, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., Marette, A. (2007). Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 104: 14056-14061 [Abstract] [Full Text]
Bilanges, B., Argonza-Barrett, R., Kolesnichenko, M., Skinner, C., Nair, M., Chen, M., Stokoe, D. (2007). Tuberous Sclerosis Complex Proteins 1 and 2 Control Serum-Dependent Translation in a TOP-Dependent and -Independent Manner. Mol. Cell. Biol. 27: 5746-5764 [Abstract] [Full Text]
Dormond, O., Madsen, J. C., Briscoe, D. M. (2007). The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells. J. Biol. Chem. 282: 23679-23686 [Abstract] [Full Text]
Mieulet, V., Roceri, M., Espeillac, C., Sotiropoulos, A., Ohanna, M., Oorschot, V., Klumperman, J., Sandri, M., Pende, M. (2007). S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Am. J. Physiol. Cell Physiol. 293: C712-C722 [Abstract] [Full Text]
Oshiro, N., Takahashi, R., Yoshino, K.-i., Tanimura, K., Nakashima, A., Eguchi, S., Miyamoto, T., Hara, K., Takehana, K., Avruch, J., Kikkawa, U., Yonezawa, K. (2007). The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1. J. Biol. Chem. 282: 20329-20339 [Abstract] [Full Text]
Wang, L., Harris, T. E., Roth, R. A., Lawrence, J. C. Jr (2007). PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding. J. Biol. Chem. 282: 20036-20044 [Abstract] [Full Text]
Rosner, M., Freilinger, A., Hanneder, M., Fujita, N., Lubec, G., Tsuruo, T., Hengstschlager, M. (2007). p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 16: 1541-1556 [Abstract] [Full Text]
Fuchs, B. C., Finger, R. E., Onan, M. C., Bode, B. P. (2007). ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. Am. J. Physiol. Cell Physiol. 293: C55-C63 [Abstract] [Full Text]
Tzatsos, A., Tsichlis, P. N. (2007). Energy Depletion Inhibits Phosphatidylinositol 3-Kinase/Akt Signaling and Induces Apoptosis via AMP-activated Protein Kinase-dependent Phosphorylation of IRS-1 at Ser-794. J. Biol. Chem. 282: 18069-18082 [Abstract] [Full Text]
Hayashi, A. A., Proud, C. G. (2007). The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. Am. J. Physiol. Endocrinol. Metab. 292: E1647-E1655 [Abstract] [Full Text]
Juvet, S. C., McCormack, F. X., Kwiatkowski, D. J., Downey, G. P. (2007). Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans. Am. J. Respir. Cell Mol. Bio. 36: 398-408 [Abstract] [Full Text]
Wang, C., Mao, X., Wang, L., Liu, M., Wetzel, M. D., Guan, K.-L., Dong, L. Q., Liu, F. (2007). Adiponectin Sensitizes Insulin Signaling by Reducing p70 S6 Kinase-mediated Serine Phosphorylation of IRS-1. J. Biol. Chem. 282: 7991-7996 [Abstract] [Full Text]
Weisman, R., Roitburg, I., Schonbrun, M., Harari, R., Kupiec, M. (2007). Opposite Effects of Tor1 and Tor2 on Nitrogen Starvation Responses in Fission Yeast. Genetics 175: 1153-1162 [Abstract] [Full Text]
Towler, M. C., Hardie, D. G. (2007). AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling. Circ. Res. 100: 328-341 [Abstract] [Full Text]
Yoshida, C., Yoshida, F., Sears, D. E., Hart, S. M., Ikebe, D., Muto, A., Basu, S., Igarashi, K., Melo, J. V. (2007). Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1. Blood 109: 1211-1219 [Abstract] [Full Text]
Ju, J.-S., Gitcho, M. A., Casmaer, C. A., Patil, P. B., Han, D.-G., Spencer, S. A., Fisher, J. S. (2007). Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase. Am. J. Physiol. Cell Physiol. 292: C564-C572 [Abstract] [Full Text]
Cao, Y., Kamioka, Y., Yokoi, N., Kobayashi, T., Hino, O., Onodera, M., Mochizuki, N., Nakae, J. (2006). Interaction of FoxO1 and TSC2 Induces Insulin Resistance through Activation of the Mammalian Target of Rapamycin/p70 S6K Pathway. J. Biol. Chem. 281: 40242-40251 [Abstract] [Full Text]
Ma, Z., Gibson, S. L., Byrne, M. A., Zhang, J., White, M. F., Shaw, L. M. (2006). Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis. Mol. Cell. Biol. 26: 9338-9351 [Abstract] [Full Text]
Guo, S., Dunn, S. L., White, M. F. (2006). The Reciprocal Stability of FOXO1 and IRS2 Creates a Regulatory Circuit that Controls Insulin Signaling. Mol. Endocrinol. 20: 3389-3399 [Abstract] [Full Text]
Morino, K., Petersen, K. F., Shulman, G. I. (2006). Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction. Diabetes 55: S9-S15 [Abstract] [Full Text]
Panasyuk, G., Nemazanyy, I., Zhyvoloup, A., Bretner, M., Litchfield, D. W., Filonenko, V., Gout, I. T. (2006). Nuclear Export of S6K1 II Is Regulated by Protein Kinase CK2 Phosphorylation at Ser-17. J. Biol. Chem. 281: 31188-31201 [Abstract] [Full Text]
Yang, Q., Inoki, K., Ikenoue, T., Guan, K.-L. (2006). Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.. Genes Dev. 20: 2820-2832 [Abstract] [Full Text]
Wang, X., Proud, C. G. (2006). The mTOR Pathway in the Control of Protein Synthesis.. Physiology 21: 362-369 [Abstract] [Full Text]
Yu, J., Henske, E. P. (2006). Estrogen-Induced Activation of Mammalian Target of Rapamycin Is Mediated via Tuberin and the Small GTPase Ras Homologue Enriched in Brain. Cancer Res. 66: 9461-9466 [Abstract] [Full Text]
Shah, O. J., Hunter, T. (2006). Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis.. Mol. Cell. Biol. 26: 6425-6434 [Abstract] [Full Text]
Draznin, B. (2006). Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85{alpha}: The Two Sides of a Coin.. Diabetes 55: 2392-2397 [Abstract] [Full Text]
Di Paolo, S., Teutonico, A., Leogrande, D., Capobianco, C., Schena, P. F. (2006). Chronic Inhibition of Mammalian Target of Rapamycin Signaling Downregulates Insulin Receptor Substrates 1 and 2 and AKT Activation: A Crossroad between Cancer and Diabetes?. J. Am. Soc. Nephrol. 17: 2236-2244 [Abstract] [Full Text]
Jiang, X., Yeung, R. S. (2006). Regulation of Microtubule-Dependent Protein Transport by the TSC2/Mammalian Target of Rapamycin Pathway.. Cancer Res. 66: 5258-5269 [Abstract] [Full Text]
Yang, Q., Inoki, K., Kim, E., Guan, K.-L. (2006). TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc. Natl. Acad. Sci. USA 103: 6811-6816 [Abstract] [Full Text]
Zeng, Z., Samudio, I. J., Zhang, W., Estrov, Z., Pelicano, H., Harris, D., Frolova, O., Hail, N. Jr., Chen, W., Kornblau, S. M., Huang, P., Lu, Y., Mills, G. B., Andreeff, M., Konopleva, M. (2006). Simultaneous Inhibition of PDK1/AKT and Fms-Like Tyrosine Kinase 3 Signaling by a Small-Molecule KP372-1 Induces Mitochondrial Dysfunction and Apoptosis in Acute Myelogenous Leukemia.. Cancer Res. 66: 3737-3746 [Abstract] [Full Text]
Hardie, D. G., Sakamoto, K. (2006). AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle. Physiology 21: 48-60 [Abstract] [Full Text]
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., Baselga, J., Rosen, N. (2006). mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt. Cancer Res. 66: 1500-1508 [Abstract] [Full Text]
He, G., Sung, Y. M., DiGiovanni, J., Fischer, S. M. (2006). Thiazolidinediones Inhibit Insulin-Like Growth Factor-I-Induced Activation of p70S6 Kinase and Suppress Insulin-Like Growth Factor-I Tumor-Promoting Activity. Cancer Res. 66: 1873-1878 [Abstract] [Full Text]
Tzatsos, A., Kandror, K. V. (2006). Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation. Mol. Cell. Biol. 26: 63-76 [Abstract] [Full Text]
Talukdar, I., Szeszel-Fedorowicz, W., Salati, L. M. (2005). Arachidonic Acid Inhibits the Insulin Induction of Glucose-6-phosphate Dehydrogenase via p38 MAP Kinase. J. Biol. Chem. 280: 40660-40667 [Abstract] [Full Text]
Hedhli, N., Pelat, M., Depre, C. (2005). Protein turnover in cardiac cell growth and survival. Cardiovasc Res 68: 186-196 [Abstract] [Full Text]
Kwiatkowski, D. J., Manning, B. D. (2005). Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 14: R251-R258 [Abstract] [Full Text]
Danielsson, A., Ost, A., Nystrom, F. H., Stralfors, P. (2005). Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes. J. Biol. Chem. 280: 34389-34392 [Abstract] [Full Text]
Nobukuni, T., Joaquin, M., Roccio, M., Dann, S. G., Kim, S. Y., Gulati, P., Byfield, M. P., Backer, J. M., Natt, F., Bos, J. L., Zwartkruis, F. J. T., Thomas, G. (2005). Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc. Natl. Acad. Sci. USA 102: 14238-14243 [Abstract] [Full Text]
Shi, Y., Yan, H., Frost, P., Gera, J., Lichtenstein, A. (2005). Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. Molecular Cancer Therapeutics 4: 1533-1540 [Abstract] [Full Text]
Diao, J., Asghar, Z., Chan, C. B., Wheeler, M. B. (2005). Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic {alpha}-Cells. J. Biol. Chem. 280: 33487-33496 [Abstract] [Full Text]
Lee, S. J., Ways, J. A., Barbato, J. C., Essig, D., Pettee, K., DeRaedt, S. J., Yang, S., Weaver, D. A., Koch, L. G., Cicila, G. T. (2005). Gene expression profiling of the left ventricles in a rat model of intrinsic aerobic running capacity. Physiol. Genomics 23: 62-71 [Abstract] [Full Text]
Ruvinsky, I., Sharon, N., Lerer, T., Cohen, H., Stolovich-Rain, M., Nir, T., Dor, Y., Zisman, P., Meyuhas, O. (2005). Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19: 2199-2211 [Abstract] [Full Text]
Li, S., Takeuchi, F., Wang, J.-a., Fuller, C., Pacheco-Rodriguez, G., Moss, J., Darling, T. N. (2005). MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J. Exp. Med. 202: 617-624 [Abstract] [Full Text]
Sun, S.-Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., Khuri, F. R. (2005). Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition. Cancer Res. 65: 7052-7058 [Abstract] [Full Text]
Momota, H., Nerio, E., Holland, E. C. (2005). Perifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo. Cancer Res. 65: 7429-7435 [Abstract] [Full Text]
Ma, L., Teruya-Feldstein, J., Behrendt, N., Chen, Z., Noda, T., Hino, O., Cordon-Cardo, C., Pandolfi, P. P. (2005). Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev. 19: 1779-1786 [Abstract] [Full Text]
Manning, B. D., Logsdon, M. N., Lipovsky, A. I., Abbott, D., Kwiatkowski, D. J., Cantley, L. C. (2005). Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19: 1773-1778 [Abstract] [Full Text]
Sofer, A., Lei, K., Johannessen, C. M., Ellisen, L. W. (2005). Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1. Mol. Cell. Biol. 25: 5834-5845 [Abstract] [Full Text]
Chiang, G. G., Abraham, R. T. (2005). Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase. J. Biol. Chem. 280: 25485-25490 [Abstract] [Full Text]
Inoki, K., Ouyang, H., Li, Y., Guan, K.-L. (2005). Signaling by Target of Rapamycin Proteins in Cell Growth Control. Microbiol. Mol. Biol. Rev. 69: 79-100 [Abstract] [Full Text]
Khamzina, L., Veilleux, A., Bergeron, S., Marette, A. (2005). Increased Activation of the Mammalian Target of Rapamycin Pathway in Liver and Skeletal Muscle of Obese Rats: Possible Involvement in Obesity-Linked Insulin Resistance. Endocrinology 146: 1473-1481 [Abstract] [Full Text]
Sarbassov, D. D., Guertin, D. A., Ali, S. M., Sabatini, D. M. (2005). Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex. Science 307: 1098-1101 [Abstract] [Full Text]
Meikle, L., McMullen, J. R., Sherwood, M. C., Lader, A. S., Walker, V., Chan, J. A., Kwiatkowski, D. J. (2005). A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. Hum Mol Genet 14: 429-435 [Abstract] [Full Text]
Weisman, R., Roitburg, I., Nahari, T., Kupiec, M. (2005). Regulation of Leucine Uptake by tor1+ in Schizosaccharomyces pombe Is Sensitive to Rapamycin. Genetics 169: 539-550 [Abstract] [Full Text]
Zick, Y. (2005). Ser/Thr Phosphorylation of IRS Proteins: A Molecular Basis for Insulin Resistance. Sci Signal 2005: pe4-pe4 [Abstract] [Full Text]
Nagle, J. A., Ma, Z., Byrne, M. A., White, M. F., Shaw, L. M. (2004). Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis. Mol. Cell. Biol. 24: 9726-9735 [Abstract] [Full Text]
Manning, B. D. (2004). Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J. Cell Biol. 167: 399-403 [Abstract] [Full Text]